Alkem Laboratories Ltd. Financials

NSE BSE

15:58 Sep 12

Alkem Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

5448.00

+54.50 (+1.01%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

5448.00

+54.50 (+1.01%)
15:58 Sep 12

Quality

68/100
High Financial Strength

Valuation

37/100
Mid Valuation

Technical

57/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	10634.19	11599.26	12667.58	12964.52	13303.84
Operating Expenses +	8581.27	9989.81	10422.09	10452.37	10661.28
Raw Material	4715.77	4444.47	4923.46	4954.39	4958.88
Increase Decrease in Cost	-535.48	462.37	14.12	-190.13	-99.41
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1962.71	2131.35	2201.01	2453.92	2544.9
Miscellaneous Expenses	5417.69	5726.72	6541.24	6262.23	3256.91
Operating Profit	2052.92	1609.45	2245.49	2512.15	2642.56
Other Income	162.65	216.08	310.84	493.74	509.92
Depreciation	303.96	310.42	299.3	357.16	364.36
Interest	52.37	107.36	112.41	121.7	122.37
Profit before tax and exceptio..	1859.24	1407.75	2144.62	2527.03	2665.75
Exceptional Items	-14.96	-102.98	-121.49	0	12.93
PBT	1844.28	1304.77	2023.13	2527.03	2652.82
Provision for Taxation	163.96	297.96	211.67	311.03	344.6
Net Profit	1680.32	1006.81	1811.46	2216	2334.08
NET Profit after MI	1645.62	984.17	1795.77	2165.48	2284.58
EPS	137.63	82.31	150.19	181.11	191.07
Operating Profit Margin (%)	19.3	13.88	17.73	19.38	19.86
Net Profit Margin (%)	15.47	8.48	14.18	16.7	17.17

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	53.00	55.10	55.70	55.70	56.40
FII	9.10	9.40	10.10	9.00	8.70
MF	16.70	15.00	14.00	14.90	14.70
Others	5.10	4.40	4.00	4.30	3.80

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: